FUSI, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 9.661
EU - Europa 7.556
AS - Asia 3.690
SA - Sud America 734
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 9
Totale 21.716
Nazione #
US - Stati Uniti d'America 9.549
RU - Federazione Russa 1.706
GB - Regno Unito 1.526
CN - Cina 1.470
SG - Singapore 1.142
IE - Irlanda 1.038
IT - Italia 968
BR - Brasile 622
SE - Svezia 535
UA - Ucraina 523
DE - Germania 375
FR - Francia 346
HK - Hong Kong 295
KR - Corea 233
FI - Finlandia 214
VN - Vietnam 170
IN - India 107
TR - Turchia 79
ES - Italia 67
CA - Canada 60
AR - Argentina 40
EE - Estonia 40
NL - Olanda 33
AT - Austria 29
BD - Bangladesh 29
MX - Messico 29
BE - Belgio 28
CZ - Repubblica Ceca 28
EC - Ecuador 22
JP - Giappone 21
PL - Polonia 21
ZA - Sudafrica 18
ID - Indonesia 17
IQ - Iraq 17
IR - Iran 14
MA - Marocco 13
CL - Cile 12
PK - Pakistan 12
CO - Colombia 11
GR - Grecia 11
AZ - Azerbaigian 10
BG - Bulgaria 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
AU - Australia 8
EG - Egitto 8
PE - Perù 8
RO - Romania 8
DK - Danimarca 7
EU - Europa 7
HU - Ungheria 7
LT - Lituania 7
UY - Uruguay 7
UZ - Uzbekistan 7
IL - Israele 6
DZ - Algeria 5
JM - Giamaica 5
PH - Filippine 5
PT - Portogallo 5
RS - Serbia 5
VE - Venezuela 5
CH - Svizzera 4
CI - Costa d'Avorio 4
PA - Panama 4
PY - Paraguay 4
AF - Afghanistan, Repubblica islamica di 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KE - Kenya 3
KZ - Kazakistan 3
NP - Nepal 3
AL - Albania 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CY - Cipro 2
ET - Etiopia 2
HN - Honduras 2
IS - Islanda 2
JO - Giordania 2
KH - Cambogia 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
DM - Dominica 1
GH - Ghana 1
IM - Isola di Man 1
LV - Lettonia 1
MK - Macedonia 1
Totale 21.705
Città #
Dallas 1.499
Southend 1.343
Fairfield 1.091
Dublin 1.018
Ashburn 808
Singapore 623
Chandler 549
Moscow 476
Woodbridge 459
Santa Clara 428
Seattle 420
Jacksonville 415
Beijing 400
Wilmington 390
Cambridge 367
Houston 359
Siena 307
Hong Kong 295
Ann Arbor 291
Seoul 231
Hefei 215
Princeton 168
Nanjing 158
Los Angeles 145
Fremont 98
Boardman 96
Helsinki 93
New York 92
Florence 83
Munich 78
The Dalles 74
San Diego 64
Milan 63
Columbus 62
Council Bluffs 62
Shanghai 60
San Mateo 59
Izmir 56
Bengaluru 54
Buffalo 52
Málaga 49
Washington 49
Ho Chi Minh City 48
São Paulo 48
Nanchang 45
Menlo Park 42
Redondo Beach 40
Dong Ket 39
Tianjin 38
Hebei 36
London 36
Shenyang 35
Rome 33
San Francisco 33
Hanoi 29
Brussels 28
Chicago 28
Turku 24
Changsha 22
Rio de Janeiro 21
Düsseldorf 19
Tokyo 19
Toronto 19
Dearborn 18
Falls Church 18
Lappeenranta 18
Phoenix 18
Jiaxing 17
Vienna 17
Guangzhou 16
Montreal 16
Hangzhou 15
Warsaw 15
Atlanta 14
Belo Horizonte 14
Brescia 14
Jinan 14
Lauterbourg 14
Nuremberg 14
Torino 14
Zhengzhou 14
Baghdad 13
Brasília 13
Brno 13
Denver 13
Frankfurt am Main 13
Redwood City 13
Amsterdam 12
Citta 12
Johannesburg 12
Olomouc 12
Stockholm 12
Boston 11
Jakarta 11
Mumbai 11
Norwalk 11
Portsmouth 11
Taizhou 11
Campinas 10
Kunming 10
Totale 14.885
Nome #
The insulin-releasing agent quercetin-3-oleate stimulates CaV1.2 channels similarly to quercetin, though with a reduced vasorelaxant activity 414
Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]- N -[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues 378
Antihypertensive, cardio-and neuroprotective effects of Tenebrio molitor (Coleoptera: Tenebrionidae) defatted larvae in spontaneously hypertensive rats 330
From in silico to in vitro: A trip to reveal flavonoid binding on the Rattus norvegicus Kir6.1 ATP-sensitive inward rectifier potassium channel 320
2-Aryl- and 2-amido-benzothiazoles as multifunctional vasodilators on rat artery preparations 272
Functional, electrophysiological and molecular docking analysis of the modulation of Cav 1.2 channels in rat vascular myocytes by murrayafoline A 264
Cav1.2 channel current block by the PKA inhibitor H-89 in rat tail artery myocytes via a PKA-independent mechanism: Electrophysiological, functional, and molecular docking studies 258
Effects of taurine and structurally related analogues on Ca2+ uptake and respiration rate in rat liver mitochondria 254
The surge of flavonoids as novel, fine regulators of cardiovascular Cav channels 250
Gold nanoparticles potentiate CaVchannel currents in rat tail artery myocytes 249
3,5-dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7): a new multidrug resistance inhibitor devoid of effects on Langendorff-perfused rat heart 243
Vasoactivity of Mantonico and Pecorello grape pomaces on rat aorta rings: An insight into nutraceutical development 241
Calcium antagonist and antiperoxidant properties of some hindered phenols 237
Cyclooxygenase activity of hemoglobin. 236
In vitro vascular toxicity of tariquidar, a potential tool for in vivo PET studies 235
Calcium channel antagonists discovered by a multidisciplinary approach 234
In vitro assessement of tariquidar toxicity towards vasculature 233
2,5-Di-t-butyl-1,4-benzohydroquinone (BHQ) inhibits vascular L-type Ca2+ channel via superoxide anion generation 230
(+/-)-Naringenin as large conductance Ca2+-activated K+ (BKCa) channel opener in vascular smooth muscle cells 227
3,5-Dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7) as a new multidrug resistance reverting agent devoid of effects on vascular smooth muscle contractility 225
Screening for potential hazard effects from multitarget anthracycline on the cardiovascular system 224
2,5-Di-t-butyl-1,4-benzohydroquinone induces endothelium-dependent relaxation of rat thoracic aorta 222
Cancer cell permeability-glycoprotein as a target of MDR reverters: possible role of novel dihydropyridine derivatives 221
Anthracene based compounds as new L-type Ca2+ channel blockers: design, synthesis, and full biological profile 221
The vasodilator papaverine stimulates L-type Ca(2+) current in rat tail artery myocytes via a PKA-dependent mechanism 221
Heat-stress-induced hyperthermia alters CSF osmolality and composition in conscious rabbits 215
Ca2+ entry blocking and contractility promoting actions of norbormide in single rat caudal artery myocytes 215
3,5-di-t-butylcatechol (DTCAT) as an activator of rat skeletal muscle ryanodine receptor Ca2+ channel (RyRC) 214
Understanding Oxadiazolothiazinone Biological Properties: Negative Inotropic Activity versus Cytochrome P450-Mediated Metabolism 214
On the mechanisms of the antispasmodic action of some hindered phenols in rat aorta rings 213
Vascular toxicity risk assessment of MC18 and MC70, novel potential diagnostic tools for in vivo PET studies 213
3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility 210
Characterization of voltage-gated calcium currents in freshly isolated smooth muscle cells from rat tail main artery 209
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 209
Antagonism by taurine on the ruthenium red-induced and 6-hydroxydopamine plus 1-methyl-4-phenylpyridinium-induced Ca2+ release from rat liver mitochondria 208
MC225, a novel probe for P-glycoprotein PET Imaging at the blood-brain barrier: in vitro cardiovascular safety evaluation 208
3,5-Di-t-butylcatechol as a ryanodine receptor agonist in rat intact skeletal muscle fibers 208
Vascular Toxicity Risk Assessment of MC18 and MC70, Novel Potential Diagnostic Tools for In Vivo PET Studies 205
Failure Effect Analysis of Patch-Clamp Electronic Instrumentation in Electrophysiology Experiments 202
Toxic injury to rat gut musculature following intraperitoneal administration of 2-t-butyl-4-methoxyphenol 202
Flavonoids and hERG channels: Friends or foes? 201
A multitarget semi-synthetic derivative of the flavonoid morin with improved in vitro vasorelaxant activity: Role of CaV1.2 and KCa1.1 channels 201
Potentiation of mitochondrial Ca2+ sequestration by taurine 198
The beneficial health effects of flavonoids on the cardiovascular system: focus on K+ channels 197
Design, synthesis and pharmacological evaluation of ester-based quercetin derivatives as selective vascular KCa1.1 channel stimulators 195
Interference measurements and failure analysis of patch-clamp laboratory instrumentation for electrophysiology tests 190
Stereoselective behavior of the functional diltiazem analogue 1-[(4-chlorophenyl)sulfonyl]-2-(2-thienyl)pyrrolidine, a new L-type calcium channel blocker 189
2-Hydroxy-5-(3,5,7-trihydroxy-4-oxo-4H-chromen-2-yl)phenyl(E)-3-(4-hydroxy-3-methoxyphenyl)acrylate: synthesis, in silico analysis and in vitro pharmacological evaluation 187
In vitro vasoactivity of zerumbone from Zingiber zerumbet 186
The selective rat toxicant norbormide blocks KATP channels in smooth muscle cells but not in insulin-secreting cells 186
Cardamonin is a bifunctional vasodilator that inhibits Cav1.2 current and stimulates KCa1.1 current in rat tail artery myocytes 185
3,5-Di-t-butyl-4-hydroxyanisole (DTBHA) activation of rat skeletal muscle sarcoplasmic reticulum Ca2+-ATPase 182
Vasorelaxing activity of R-(-)-3'-Hydroxy-2,4,5-trimethoxydalbergiquinol from Dalbergia tonkinensis: involvement of smooth muscle CaV1.2 Channels 181
Reversion of nitrate tolerance in rat aorta rings by freeze-dried red wine 180
The mitochondrial permeability transition and taurine 179
Pharmacokinetic of diphenydramine in young volunteers with a dimenhydrinate 25 mg chewing gum formulation 179
Sdox, a H2S releasing anthracycline, with a safer profile than doxorubicin toward vasculature 178
L-type Ca2+ channel current characteristics are preserved in rat tail artery myocytes after one-day storage 176
Extra virgin olive oil extracts of indigenous Southern Tuscany cultivar act as anti-inflammatory and vasorelaxant nutraceuticals 176
Effects of 2,5-di-t-butyl-1,4-benzohydroquinone (BHQ) on rat aorta smooth muscle 172
The novel potent multidrug resistance inhibitors N,N-bis(cyclohexanol)amine aryl esters are devoid of vascular effects 171
L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives 170
Cholinesterase inhibitors increase secretion of APPs in rat brain cortex 170
Can food antioxidants prevent cancer and cardiovascular diseases? 169
Quercetin mitochondriotropic derivatives antagonize nitrate tolerance and endothelial dysfunction of isolated rat aorta rings 169
Myorelaxant activity of 2-t-butyl-4-methoxyphenol (BHA) in guinea pig gastric fundus 168
Vascular activity of two silicon compounds, ALIS 409 and ALIS 421, novel multidrug-resistance reverting agents in cancer cells 167
The possible role of taurine and GABA as endogenous cryogens in the rabbit: changes in CSF levels in heat-stress 166
Neuroprotection afforded by some hindered phenols and a-tocopherol in guinea-pig detrusor strips subjected to anoxia-glucopenia and reperfusion-like conditions. 164
Effects of some sterically hindered phenols on whole-cell Ca2+ current of guinea pig gastric fundus smooth muscle cells 163
Quercetin as a novel activator of L-type Ca2+ channels in rat tail artery smooth muscle cells 163
Rectal temperature and prostaglandin E2 increase in cerebrospinal fluid of conscious rabbits after intracerebroventricular injection of hemoglobin 163
Relaxant and Ca2+ channel blocking properties of norbormide on rat non-vascular smooth muscles 162
Mechanism of myricetin stimulation of vascular L-type Ca2+ current 157
Quercetin antagonism of Bay K 8644 effects on rat tail artery L-type Ca(2+) channels 156
Playing with opening and closing of heterocycles: using the Cusmano-Ruccia reaction to develop a novel class of oxadiazolothiazinones, active as calcium channel modulators and p-glycoprotein inhibitors 154
L-type Ca2+ channels activation and contraction elicited by myricetin on vascular smooth muscles 152
Fine tuning by protein kinases of CaV1.2 channel current in rat tail artery myocytes 151
Vasorelaxing activity of two coumarins from Murraya paniculata leaves 150
Effects of commonly used protein kinase inhibitors on vascular contraction and L-type Ca2+ current 149
Tyrosine kinase inhibitor Si409 has in vitro and in vivo anti-tumor activity against diffuse large B-cell lymphoma 147
Discovery of novel and cardioselective diltiazem-like calcium channel blockers via virtual screening 147
Mechanisms of the antispasmodic activity of 3,5-di-t-butyl catechol (DTCAT) on rat vascular smooth muscles 146
Artificial intelligence-driven identification of morin analogues acting as CaV1.2 channel blockers: synthesis and biological evaluation 145
Cytochrome P450-dependent N-dealkylation of L-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, beta-naphthoflavone and L-deprenyl 144
Vietnamese Dalbergia tonkinensis: A Promising Source of Mono- and Bifunctional Vasodilators 143
The Enigma of Norbormide, a Rattus-Selective Toxicant 143
The flavonoid scaffold as a template for the design of modulators of the vascular Cav1.2 channels 143
Dynamin-independent CaV1.2 and KCa1.1 channels regulation and vascular tone modulation by the mitochondrial fission inhibitors dynasore and dyngo-4a 141
Quercetin relaxes rat tail main artery partly via a PKG-mediated stimulation of KCa1.1 channels 140
Functional, electrophysiology, and molecular dynamics analysis of quercetin-induced contraction of rat vascular musculature 140
In vitro vascular toxicity assessment of NitDOX, a novel NO-releasing doxorubicin 139
A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors 138
Novel Labdane Diterpenes-Based Synthetic Derivatives: Identification of a Bifunctional Vasodilator That Inhibits CaV1.2 and Stimulates KCa1.1 Channels 134
Traceability and authentication in agri-food production: A multivariate approach to the characterization of the Italian food excellence elephant garlic (Allium ampeloprasum L.), a vasoactive nutraceutical 132
The interaction of antioxidants and structurally related compounds with mitochondrial oxidative phosphorylation 129
Mechanism of osthole inhibition of vascular Cav1.2 current 128
Vascular L-type Ca2+ channel blocking activity of sulphur-containing indole alkaloids from Glycosmis petelotii 127
In vitro and in silico analysis of the vascular effects of asymmetrical N,N-bis(alkanol)amine aryl esters, novel multidrug resistance-reverting agents 126
Interaction of butylated hydroxyanisole with mitochondrial oxidative phosphorylation 125
Totale 19.293
Categoria #
all - tutte 69.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.856


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.455 0 0 0 0 0 286 98 301 181 268 170 151
2021/20221.628 98 229 113 123 73 71 111 55 96 173 173 313
2022/20232.150 132 193 292 305 167 386 71 198 218 70 80 38
2023/20241.892 87 31 187 87 107 506 569 36 13 37 47 185
2024/20253.638 94 162 312 209 445 227 178 240 326 183 405 857
2025/20265.496 669 1.187 1.212 861 1.521 46 0 0 0 0 0 0
Totale 21.991